208465-69-4

Basic information

• Product Name: (R)-((3R,4R,E)-7-((S,2E,4E)-8-(tert-butyldimethylsilyloxy)-6-(tert-butyldiphenylsilyloxy)-4-methylocta-2,4-dienylamino)-2,4-dimethyl-7-oxohept-5-en-3-yl) 1-(2-(chloromethyl)-oxazole-4-carbonyl)pyrrolidine-2-carboxylate
• Synonyms: (R)-((3R,4R,E)-7-((S,2E,4E)-8-(tert-butyldimethylsilyloxy)-6-(tert-butyldiphenylsilyloxy)-4-methylocta-2,4-dienylamino)-2,4-dimethyl-7-oxohept-5-en-3-yl) 1-(2-(chloromethyl)-oxazole-4-carbonyl)pyrrolidine-2-carboxylate
• CAS NO: 208465-69-4
• Molecular Weight: 918.762
• Mol File: 208465-69-4.mol

Chemical Properties

• CAS DataBase Reference: (R)-((3R,4R,E)-7-((S,2E,4E)-8-(tert-butyldimethylsilyloxy)-6-(tert-butyldiphenylsilyloxy)-4-methylocta-2,4-dienylamino)-2,4-dimethyl-7-oxohept-5-en-3-yl) 1-(2-(chloromethyl)-oxazole-4-carbonyl)pyrrolidine-2-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-((3R,4R,E)-7-((S,2E,4E)-8-(tert-butyldimethylsilyloxy)-6-(tert-butyldiphenylsilyloxy)-4-methylocta-2,4-dienylamino)-2,4-dimethyl-7-oxohept-5-en-3-yl) 1-(2-(chloromethyl)-oxazole-4-carbonyl)pyrrolidine-2-carboxylate(208465-69-4)
• EPA Substance Registry System: (R)-((3R,4R,E)-7-((S,2E,4E)-8-(tert-butyldimethylsilyloxy)-6-(tert-butyldiphenylsilyloxy)-4-methylocta-2,4-dienylamino)-2,4-dimethyl-7-oxohept-5-en-3-yl) 1-(2-(chloromethyl)-oxazole-4-carbonyl)pyrrolidine-2-carboxylate(208465-69-4)

Safety Data

• Hazardous Substances Data: 208465-69-4(Hazardous Substances Data)

Upstream product

• 180779-81-1 (3R,4R,E)-2,4-dimethyl-7-oxo-7-(prop-2-ynylamino)hept-5-en-3-yl acetate 
• 180779-80-0 (4R,5R,E)-5-hydroxy-4,6-dimethyl-N-(prop-2-yn- 1-yl)hept-2-enamide 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 89922-82-7 3-(tert-butyldimethylsilanyloxy)propionaldehyde 
• 73842-99-6 3-tert-butyldimethylsilyloxy-1-propanol 
• 1346661-76-4 (3R,4R,E)-7-((S,2E,4E)-8-(tert-butyldimethylsilyloxy)-6-(tertbutyldiphenylsilyloxy)-4-methylocta-2,4-dienylamino)-2,4-dimethyl-7-oxohept-5-en-3-yl acetate 
• 1346661-60-6 (S,E)-1-(tert-butyl(1-(tert-butyldimethylsilyloxy)-5-iodohex-4-en-3-yloxy)(phenyl)silyl)benzene 
• 1346661-73-1 (3R,4R,E)-7-((E)-3-iodoallylamino)-2,4-dimethyl-7-oxohept-5-en-3-yl acetate 
• 1346661-58-2 1-(tert-butyldimethylsilyloxy)hex-4-yn-3-one 
• 1246937-60-9 (R)-benzyl 1-(2-(chloromethyl)oxazole-4-carbonyl)-pyrrolidine-2-carboxylate 
• 1246937-58-5 (4R,5R,E)-N-((S,2E,4E)-8-(tert-butyldimethylsilyloxy)-6-hydroxy-4-methylocta-2,4-dienyl)-5-hydroxy-4,6-dimethylhept-2-enamide 
• 1246937-67-6 rac-1-(tert-butyldimethylsilyloxy)hex-4-yn-3-ol 
• 1246937-47-2 (S)-1-(tert-butyldimethylsilyloxy)hex-4-yn-3-ol 
• 159420-55-0 C₆H₈N₂O₂ 

Downstream Products

• 1246937-61-0 (R)-((3R,4R,E)-7-((S,2E,4E)-6-(tert-butyldiphenylsilyloxy)-4-methyl-8-oxoocta-2,4-dienylamino)-2,4-dimethyl-7-oxohept-5-en-3-yl) 1-(2-(chloromethyl)oxazole-4-carbonyl)pyrrolidine-2-carboxylate 
• 318279-50-4 C₄₄H₅₇N₃O₇Si 
• 1346661-79-7 C₄₄H₅₇N₃O₇Si 
• 208465-71-8 (R)-1-(2-Iodomethyl-oxazole-4-carbonyl)-pyrrolidine-2-carboxylic acid (E)-(1R,2R)-4-[(2E,4E)-(S)-6-(tert-butyl-diphenyl-silanyloxy)-8-hydroxy-4-methyl-octa-2,4-dienylcarbamoyl]-1-isopropyl-2-methyl-but-3-enyl ester 
• 208465-60-5 (R)-((3R,4R,E)-7-((S,2E,4E)-6-(tert-butyldiphenylsilyloxy)-4-methyl-8-oxoocta-2,4-dienylamino)-2,4-dimethyl-7-oxohept-5-en-3-yl) 1-(2-(iodomethyl)oxazole-4-carbonyl)pyrrolidine-2-carboxylate 
• 208465-70-7 (R)-((3R,4R,E)-7-((S,2E,4E)-6-(tert-butyldiphenylsilyloxy)-8-hydroxy-4-methylocta-2,4-dienylamino)-2,4-dimethyl-7-oxohept-5-en-3-yl) 1-(2-(chloromethyl)oxazole-4-carbonyl)pyrrolidine-2-carboxylate 

Relevant articles and documents

Total synthesis of (-)-virginiamycin m2: Application of crotylsilanes accessed by enantioselective Rh(II) or Cu(I) promoted carbenoid Si-H insertion

A stereoselective synthesis of the antibiotic (-)-virginiamycin M 2 is detailed. A convergent strategy was utilized that proceeded in 10 steps (longest linear sequence) from enantioenriched silane (S)-15. This reagent, which was prepared via a Rh(II)- or Cu(I)-catalyzed carbenoid Si-H insertion, was used to introduce the desired olefin geometry and stereocenters of the C1-C5 propionate subunit. A modified Negishi cross-coupling or an efficient alkoxide-directed titanium-mediated alkyne-alkyne reductive coupling strategy was utilized to assemble the trisubstituted (E,-E)-diene. An underutilized late-stage SmI2-mediated macrocyclization was employed to construct the 23-membered macrocycle scaffold of the natural product (Figure presented).

Total synthesis of (-)-virginiamycin M2

Has a nice ring to it: A concise and modular total synthesis of the naturally occurring antibiotic virginiamycin M2 is described. A Barbier-type cyclization was used to close the 23-membered macrocycle and deliver virginiamycin M2 in 19 steps from a chiral organosilane.

Total synthesis of pristinamycin II(B)

An intramolecular Takai reaction of the iodoaldehyde 4a proceeded with a moderate efficiency to give the macrocyclic hydroxy compound 1b, identified to an authentic sample.